人类生长激素用于低反应者:一项随机安慰剂对照试验未提供改善活产率的证据
该双盲、安慰剂对照随机临床试验比较体外受精周期中加用人类生长激素与安慰剂对既往对卵泡刺激素低反应者的活产率影响,研究在4年后停止,计划样本量未达到。活产率生长激素组为9/62(14.5%),安慰剂组为7/51(13.7%),风险差0.8%(95%CI -12.1至13.7%),OR 1.07(95%CI 0.37-3.10)。结论为无法证明加用生长激素可提高既往低反应者的活产率。
要点
- 生长激素组活产率14.5%(9/62),安慰剂组13.7%(7/51),差异未达统计学显著。
- 生长激素组获卵的比值比OR 5.67(95%CI 1.54-20.80),但胚胎移植机会OR 1.42(95%CI 0.50-4.00)。
- 研究计划样本量未达到,无法证明生长激素提高既往低反应者的活产率。
核心结论
- 计划参与人数未达到,无法证明在既往对体外受精卵巢低反应女性中加用生长激素可提高活产率。
研究设计与样本
- 双盲、安慰剂对照随机临床试验,在体外受精周期最大刺激方案中比较人类生长激素与安慰剂,研究在4年后停止。
- 纳入标准为既往周期中每日卵泡刺激素超过250 IU仍未获得超过5个卵子的女性,基础卵泡刺激素≤15 IU/l、体重指数<33 kg/m2、年龄<41岁。
- 人类生长激素或安慰剂从周期开始时以双盲方式加入,主要结局为活产率。
主要发现
- 体外受精周期后活产率生长激素组为9/62(14.5%),安慰剂组为7/51(13.7%),风险差0.8%(95%CI -12.1至13.7%),OR 1.07(95%CI 0.37-3.10)。
- 生长激素组获卵的比值比OR 5.67(95%CI 1.54-20.80),胚胎移植机会OR 1.42(95%CI 0.50-4.00)。
- 出生体重两组相当。
局限性
- 计划参与人数未达到。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does the addition of human growth hormone (HGH) to an IVF cycle improve the live birth rate in previously documented poor responders to FSH? DESIGN: Double-blind, placebo-controlled, randomized clinical trial comparing HGH to placebo in maximal stimulation in an IVF cycle. The study was stopped after 4 years. Women receiving ovarian stimulation in one IVF cycle, having failed to produce more than 5 eggs in a previous cycle with more than 250 IU/day of FSH were included. Basal FSH was ≤15 IU/l, body mass index <33 kg/m2, age <41 years. HGH or placebo were added from the start of the cycle in a double-blinded manner. The primary outcome was live birth rate. MAIN RESULTS: The live birth rates following an IVF cycle were 9/62 (14.5%) for growth hormone and 7/51 (13.7%) for the placebo group (risk difference 0.8%, 95% confidence interval [CI] -12.1 to 13.7%; odds ratio [OR] 1.07, 95% CI 0.37-3.10). There was a greater odds of oocyte retrieval with growth hormone (OR 5.67, 95% CI 1.54-20.80) but no better chance of embryo transfer (OR 1.42, 95% CI 0.50-4.00). Birth weights were comparable. CONCLUSIONS: Planned participant numbers were not reached. It was not possible to demonstrate an increase in live birth rate from the addition of growth hormone in women with a previous poor ovarian response to IVF.
引用
- Norman RJ, Alvino H, Hull LM, et al. Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate. Reprod Biomed Online. 2019. PMID: 30954433. doi:10.1016/j.rbmo.2019.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。